Stephen Dale
2020
In 2020, Stephen Dale earned a total compensation of $3.3M as Chief Medical Officer at Kura Oncology.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $81,782 |
| Option Awards | $2,887,220 |
| Salary | $158,602 |
| Other | $8,550 |
| Total | $3,286,154 |
Dale received $2.9M in option awards, accounting for 88% of the total pay in 2020.
Dale also received $150K in bonus, $81.8K in non-equity incentive plan, $158.6K in salary and $8.6K in other compensation.
Rankings
In 2020, Stephen Dale's compensation ranked 3,551st out of 13,090 executives tracked by ExecPay. In other words, Dale earned more than 72.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,551 out of 13,090 | 73rd |
Division Manufacturing | 1,387 out of 5,621 | 75th |
Major group Chemicals And Allied Products | 523 out of 2,254 | 77th |
Industry group Drugs | 454 out of 1,954 | 77th |
Industry Pharmaceutical Preparations | 340 out of 1,459 | 77th |
Pay ratio
| Stephen Dale's Pay | $3,286,154 |
|---|---|
| Median Employee's Pay | $346,674 |
| Pay Ratio | 9to 1 |
In 2020, the annual total compensation of Stephen Dale was $3,286,154.
The annual total compensation of the median employee at Kura Oncology was $346,674.
The ratio of Stephen Dale's pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on April 29, 2021.
Dale's colleagues
We found five more compensation records of executives who worked with Stephen Dale at Kura Oncology in 2020.